Chronic Inducible Urticaria Diagnosis and Management
Diagnostic Approach
- The British Journal of Dermatology notes that delayed pressure urticaria appears after sustained pressure on the skin, and other forms like heat urticaria, solar urticaria, and vibratory angioedema are triggered by specific stimuli 1
- The Journal of Allergy and Clinical Immunology recommends provocation testing to confirm the diagnosis and identify the specific trigger, with a focus on reproducing symptoms under controlled conditions 2, 3
- The Urticaria Control Test (UCT) is recommended by the Journal of Allergy and Clinical Immunology to assess disease control in all forms of chronic urticaria, including CIndU, with a score ≥12 indicating well-controlled disease 4, 5
- Individual weals in CIndU typically last less than 24 hours, distinguishing it from urticarial vasculitis where lesions persist beyond 24 hours, as noted by Praxis Medical Insights 6
Treatment Algorithm
- Brief courses of systemic corticosteroids can be used for severe flares, but not for long-term use, according to Praxis Medical Insights 6
- Cyclosporine (up to 5mg/kg body weight) can be considered for refractory cases, with appropriate monitoring of blood pressure and renal function, as recommended by Praxis Medical Insights 6
- The Journal of Allergy and Clinical Immunology suggests that treatment should focus on trigger avoidance and physical desensitization, particularly for cold urticaria, with regular assessment of disease activity and impact on quality of life guiding treatment decisions 4, 5
Important Considerations
- Some forms of CIndU, particularly cold urticaria, can potentially progress to anaphylaxis in severe cases, as noted by the British Journal of Dermatology 1
- Treatment should be continued until complete symptom control is achieved and maintained for at least 3-6 months before considering dose reduction, according to Praxis Medical Insights 6
- For pregnant women, second-generation antihistamines (particularly loratadine and cetirizine) are preferred due to their established safety profile, as recommended by Praxis Medical Insights 6